U.S. Small Molecule Innovator API CDMO Market Analysis Report 2024-2030: Increasing Demand for Small Molecule Drugs and Outsourcing Among Pharmaceutical Companies
August 06, 2024 11:29 ET
|
Research and Markets
Dublin, Aug. 06, 2024 (GLOBE NEWSWIRE) -- The "U.S. Small Molecule Innovator API CDMO Market Size, Share & Trends Analysis Report by Stage Type (Preclinical, Clinical, Commercial), Customer...
Global Pharmaceutical Contract Manufacturing Business Research Report 2024: Market to Reach $159.8 Billion by 2030 - Exploring & Exploiting New Technologies for Rich Dividends
July 31, 2024 04:17 ET
|
Research and Markets
Dublin, July 31, 2024 (GLOBE NEWSWIRE) -- The "Pharmaceutical Contract Manufacturing - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.The global market...
Integer Holdings Corporation Reports Second Quarter 2024 Results
July 25, 2024 08:00 ET
|
Integer Holdings Corporation
~ Continued strong performance with 2Q24 financial results ~~ Raising full year 2024 profit outlook ~ PLANO, Texas, July 25, 2024 (GLOBE NEWSWIRE) -- Integer Holdings Corporation (NYSE:ITGR)...
Global Nutraceuticals CDMO Industry Research 2024: Size, Share, Trends, Opportunity, and Competitive Landscape, 2019-2029F
July 22, 2024 04:46 ET
|
Research and Markets
Dublin, July 22, 2024 (GLOBE NEWSWIRE) -- The "Nutraceuticals CDMO Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2019-2029F" report has been added to ...
Crossject franchit une nouvelle étape clé dans la fabrication de ZEPIZURE®
July 18, 2024 01:30 ET
|
CROSSJECT
Fabrication réussie d’un autre Lot Règlementaire de ZEPIZURE® sur le nouveau site de fabricationUne étape importante qui complète les résultats satisfaisants obtenus avec les lots précédents dans le...
Crossject achieves key ZEPIZURE® manufacturing milestone
July 18, 2024 01:30 ET
|
CROSSJECT
Successful completion of an additional Registration Batch of ZEPIZURE® at new manufacturing siteMilestone complements the satisfying results from previous batches under stability studies, and is...
Rentschler Biopharma Announces New State-of-the-Art Production Line in Massachusetts is Fully Operational
July 11, 2024 08:00 ET
|
Rentschler Biopharma SE
Largest expansion in company’s 150+-year history opensMajor client project already underway; new clients actively being onboarded LAUPHEIM, Germany and MILFORD, Mass., July 11, 2024 (GLOBE...
Small Molecule Innovator CDMO Research Report 2024: Global Market Set to Reach US$86.247 Billion by 2029 - Government Initiatives Fueling Expansion, Addressing Chronic Disease Predominance
July 10, 2024 06:34 ET
|
Research and Markets
Dublin, July 10, 2024 (GLOBE NEWSWIRE) -- The "Small Molecule Innovator CDMO Market - Forecasts from 2024 to 2029" report has been added to ResearchAndMarkets.com's offering.The global small...
Olon Group Announces the Acquisition of GTP Bioways Group
July 03, 2024 04:30 ET
|
Olon SpA
OLON GROUP ANNOUNCES THE ACQUISITION
OF GTP BIOWAYS GROUP
GTP Bioways Group is a French company operating as Biotech CDMO (Contract Developing and Manufa
Avid Bioservices Reports Financial Results for Fourth Quarter and Fiscal Year Ended April 30, 2024
July 02, 2024 16:05 ET
|
Avid Bioservices, Inc
-- Recorded Fourth Quarter Revenue of $43.0 Million – Highest in Company History -- -- Signed $30 Million in Net New Business Resulting in Backlog of $193 Million -- -- New Mammalian and Cell and...